Tau-Centric Multitarget Approach for Alzheimer’s Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation InhibitorsAnnachiara Gandini, María Laura Bolognesi, Daniele Tedesco et al.|Journal of Medicinal Chemistry|2018Cited by 104